You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
26 September 2016
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA(R)) for Pancreatic Cancer
24 February 2016
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2015
11 January 2016
ERYTECH reports financial highlights for Q4 2015
28 September 2015
ERYTECH provides business update and financial results for the first half of 2015
30 March 2015
ERYTECH provides business update and financial results for the full year 2014
12 January 2015
ERYTECH announces ADR Level 1 listing in the US
8 December 2014
ERYTECH reports additional positive Phase III results from clinical study with ERY-ASP/GRASPA(R) in Acute Lymphoblastic Leukemia
23 October 2014
ERYTECH successfully raises EUR30 million for expanding its therapeutic indications in oncology and accelerating its clinical developments
21 October 2014
ERYTECH PHARMA SA: ERYTECH announces granting of new patent in the United States
ERYTECH announces granting of new patent in the United States
1 October 2014
ERYTECH reports positive top-line Phase III results from clinical study with GRASPA(R) in Acute Lymphoblastic Leukemia
2 September 2014
ERYTECH PHARMA SA: Business Update and Financial Results for the First Half of 2014
